---
document_datetime: 2026-01-16 09:40:07
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/entecavir-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: entecavir-viatris-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.1590671
conversion_datetime: 2026-01-17 13:36:46.555132
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.68.0
  docling-core: 2.59.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Entecavir Viatris

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IA /  | This was an application for a group of | 15/01/2026                          |                                             | Annex II and                     |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000323069   | variations.   | PL   |
|---------------------|---------------|------|

<div style=\"page-break-after: always\"></div>

|                                       | batch release, site where batch control takes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)* - Accepted B.III.1.a European Pharmacopoeial Certificate of Suitability to the relevant Ph. Eur. Monograph - B.III.1.a.2 Updated certificate from an already approved manufacturer - Accepted   |            |     |    |
|---------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----|
| Article 61(3) / EMA/N/0000309461      | - Notification acc. Article 61(3) - Accepted Update of the package leaflet with revised contact details of local representatives.                                                                                                                                                                                                              | 06/11/2025 |     | PL |
| Variation type IB / EMA/VR/0000268655 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.II.e) Container closure system - B.II.e.z Other variation - Accepted                                                                                                                           | 10/07/2025 | N/A |    |
| Article 61(3) / EMA/N/0000254071      | - Notification acc. Article 61(3) - Accepted Update of the package leaflet with revised contact details of local representatives and deletion of 'United Kingdom (Northern Ireland)' from the list of local                                                                                                                                    | 06/03/2025 |     | PL |

<div style=\"page-break-after: always\"></div>

| representatives in line with the QRD template v10.4. Additionally, the MAH took the opportunity to align the contact details of local representatives in the Dutch version with the English text.   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|